Carl Zeiss Meditec AG
CZMWY · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $2,228 | $2,066 | $2,089 | $1,903 |
| % Growth | 7.8% | -1.1% | 9.8% | – |
| Cost of Goods Sold | $1,052 | $977 | $884 | $775 |
| Gross Profit | $1,175 | $1,089 | $1,206 | $1,128 |
| % Margin | 52.8% | 52.7% | 57.7% | 59.3% |
| R&D Expenses | $326 | $343 | $349 | $291 |
| G&A Expenses | $131 | $111 | $84 | $78 |
| SG&A Expenses | $627 | $569 | $504 | $438 |
| Sales & Mktg Exp. | $495 | $458 | $420 | $360 |
| Other Operating Expenses | -$1 | $55 | $25 | $1 |
| Operating Expenses | $952 | $967 | $879 | $731 |
| Operating Income | $284 | $121 | $327 | $372 |
| % Margin | 12.7% | 5.9% | 15.7% | 19.6% |
| Other Income/Exp. Net | -$69 | $120 | $85 | $31 |
| Pre-Tax Income | $214 | $241 | $413 | $403 |
| Tax Expense | $57 | $61 | $121 | $108 |
| Net Income | $156 | $179 | $290 | $294 |
| % Margin | 7% | 8.7% | 13.9% | 15.4% |
| EPS | 1.78 | 2.01 | 3.25 | 3.29 |
| % Growth | -11.4% | -38.2% | -1.2% | – |
| EPS Diluted | 1.78 | 2.01 | 3.25 | 3.29 |
| Weighted Avg Shares Out | 88 | 89 | 89 | 89 |
| Weighted Avg Shares Out Dil | 88 | 89 | 89 | 89 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $24 | $29 | $14 |
| Interest Expense | $29 | $32 | $2 | $10 |
| Depreciation & Amortization | $126 | $38 | $74 | $70 |
| EBITDA | $347 | $225 | $502 | $483 |
| % Margin | 15.6% | 10.9% | 24% | 25.4% |